Sarepta Refuses To Stop Elevidys Shipments After Third Death Linked To Gene Therapy Vector

 
• By Mandy Jackson
  
The FDA began investigating Elevidys in June after a second DMD patient died from acute liver failure. (Shutterstock)

More from Cell & Gene Therapies

More from United States